| abstract |
(57) [Summary]nThe present invention relates to the use of at least one aminopeptidase inhibitor for the production of a medicament for use in the treatment of neoplastic and / or immunological diseases, wherein the at least one aminopeptidase inhibitor comprises a tumor cell and / or Or denaturing at least one surface protein CD13 as a member of a protein network on the surface of immune cells, resulting in a block of polarization of invasive human or animal tumor cells and / or immune cells, said protein network comprising: Includes up to 30 surface proteins from a given group. The present invention also relates to pharmaceutical preparations and methods for identifying at least one additional inhibitor that functions in combination with at least one aminopeptidase inhibitor. |